Literature DB >> 16489651

Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.

Jian-Lun Liu1, Lian-Ying Ge, Gui-Nian Zhang.   

Abstract

AIM: To study the activity of telomerase and the expression of human telomerase reverse transcriptase (hTERT) in colorectal carcinoma and its adjacent tissues, normal mucosa and adenomatoid polyp, and to evaluate their relation with carcinogenesis and progression of colorectal carcinoma.
METHODS: Telomerase activity and hTERT expression were determined in 30 samples of colorectal carcinoma and its adjacent tissues, normal mucosa and 20 samples of adenomatoid polyp by modified telomeric repeat amplification protocol (TRAP), enzyme-linked immunosorbent assay (ELISA) and immunohistochemical method.
RESULTS: Telomerase activity and hTERT expression were 83.33% (25/30) and 76.67% (23/30) respectively in colorectal carcinoma, which were obviously higher than those in paracancerous tissues (13.33%, 16.67%), normal mucosa (3.33%, 3.33%) and adenomatoid polyp (10%, 10%). There was a significant difference between colorectal carcinoma and other tissues (P=0.027). The telomerase activity and hTERT expression were higher in colorectal carcinoma with lymphatic metastasis than in that without lymphatic metastasis (P=0.034). When the histological classification and clinical stage were greater, the telomerase activity and hTERT expression increased, but there was no significant difference between them. In colorectal carcinoma, the telomerase activity was correlated with hTERT expression (positive vs negative expression of telomerase activity and hTERT, P=0.021).
CONCLUSION: Telomerase activity is closely correlated with the occurrence, development and metastasis of colorectal carcinoma. Overexpression of hTERT may play a critical role in the regulation of telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489651      PMCID: PMC4066070          DOI: 10.3748/wjg.v12.i3.465

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

Review 2.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

Review 3.  Role of telomerase in cell senescence and oncogenesis.

Authors:  V Urquidi; D Tarin; S Goodison
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

4.  Expression profile of the putative catalytic subunit of the telomerase gene.

Authors:  S Ramakrishnan; U Eppenberger; H Mueller; Y Shinkai; R Narayanan
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Reconstitution of human telomerase activity in vitro.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

7.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.

Authors:  S L Weinrich; R Pruzan; L Ma; M Ouellette; V M Tesmer; S E Holt; A G Bodnar; S Lichtsteiner; N W Kim; J B Trager; R D Taylor; R Carlos; W H Andrews; W E Wright; J W Shay; C B Harley; G B Morin
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.

Authors:  J Nakayama; H Tahara; E Tahara; M Saito; K Ito; H Nakamura; T Nakanishi; E Tahara; T Ide; F Ishikawa
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

9.  Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.

Authors:  R Tang; A J Cheng; J Y Wang; T C Wang
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

  9 in total
  5 in total

1.  Telomerase and hTERT: can they serve as markers for gastric cancer diagnosis?

Authors:  Yong-Bo Cheng; Li-Ping Guo; Ping Yao; Xiao-Yan Ning; Gulimire Aerken; Dian-Chun Fang
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

2.  The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.

Authors:  Hiromi Tanaka; Matthew J Beam; Kevin Caruana
Journal:  Neoplasia       Date:  2014-10-23       Impact factor: 5.715

3.  hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression.

Authors:  Chunli Gong; Huan Yang; Sumin Wang; Jiao Liu; Zhibin Li; Yiyang Hu; Yang Chen; Yu Huang; Qiang Luo; Yuyun Wu; En Liu; Yufeng Xiao
Journal:  Front Cell Dev Biol       Date:  2021-05-17

4.  Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.

Authors:  Tapati Mazumdar; Ranjodh Sandhu; Maha Qadan; Jennifer DeVecchio; Victoria Magloire; Akwasi Agyeman; Bibo Li; Janet A Houghton
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

5.  Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.

Authors:  Yongxin Wu; Guichao Li; Dong He; Fengping Yang; Guang He; Lin He; Hui Zhang; Yun Deng; Ming Fan; Lijun Shen; Daizhan Zhou; Zhen Zhang
Journal:  Onco Targets Ther       Date:  2016-01-11       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.